Skip to main content
. Author manuscript; available in PMC: 2020 Nov 30.
Published in final edited form as: Gastric Cancer. 2017 Jun 22;21(1):74–83. doi: 10.1007/s10120-017-0743-4

Table 4.

Univariable and multivariable Cox analysis of overall survival (OS)

Variable Univariable Multivariable
HR (95% CI) p value HR (95% CI) p value
Age at diagnosis ≥65 vs. <65 years 1.35 (0.99–1.85) 0.058 1.30 (0.93–1.84) 0.127
Sex Female vs. male 0.82 (0.60–1.13) 0.221
Race/ethnicity White (ref)
Black 1.24 (0.73–2.10) 0.430 1.31 (0.75–2.28) 0.341
Asian 0.57 (0.33–1.00) 0.052 0.52 (0.30–0.93) 0.028
Hispanic 0.89 (0.61–1.29) 0.537 0.86 (0.58–1.27) 0.444
Location GEJ vs. other 1.20 (0.85–1.69) 0.307
Histology grade Poorly vs. well/moderately differentiated 1.08 (0.73–1.61) 0.691
Signet-ring cell Yes vs. no 1.10 (0.81–1.49) 0.548
Linitis Yes or suspicious 2.27 (1.47–3.51) <0.001 1.66 (1.03–2.69) 0.037
ypStage T0N0 1.24 (0.71–2.18) 0.452 1.29 (0.73–2.28) 0.377
T0N1 4.08 (1.57–10.6) 0.004 4.34 (1.63–11.6) 0.003
1 (ref)
2 1.71 (1.09–2.67) 0.019 1.78 (1.11–2.83) 0.016
3 3.36 (2.10–5.38) <0.001 3.42 (2.08–5.60) <0.001
4 13.83 (7.30–26.2) <0.001 13.11 (6.60–26.0) <0.001
Concomitant organ resection Yes vs. no 1.63 (1.13–2.35) 0.009 1.45 (0.99–2.11) 0.057
R1 resection Yes vs. no 3.05 (1.90–4.89) <0.001 1.91 (1.13–3.23) 0.016
Preoperative XRT Yes vs. no 0.95 (0.66–1.37) 0.801
Adjuvant therapy Yes vs. no 0.90 (0.58–1.40) 0.648
Number of LNs examined <16 Yes vs. no 1.25 (0.91–1.72) 0.169 1.38 (0.98–1.95) 0.061

p values <0.05 are in bold font